Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010;38(4 Suppl):S512–21.10.1016/j.amepre.2009.12.02220331952Search in Google Scholar
Isaak EJ, LeChien B, Lindsey T, Debaun MR. The Charles Drew program in Missouri: a description of a partnership among a blood center and several hospitals to address the care of patients with sickle cell disease. Immunohematology 2006;22:112–16.10.21307/immunohematology-2019-366Search in Google Scholar
Bernaudin F, Verlhac S, Arnaud C, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 2011;117:1130–40; quiz 1436.10.1182/blood-2010-06-29351421068435Search in Google Scholar
Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5–11.10.1056/NEJM1998070233901029647873Search in Google Scholar
Hulbert ML, Scothorn DJ, Panepinto JA, et al. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. J Pediatr 2006;149:710–12.10.1016/j.jpeds.2006.06.03717095350Search in Google Scholar
Scothorn DJ, Price C, Schwartz D, et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002;140:348–54.10.1067/mpd.2002.12249811953734Search in Google Scholar
Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086–92.10.1046/j.1537-2995.2001.41091086.x11552063Search in Google Scholar
Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431–7.10.1182/blood.V76.7.1431.1431Search in Google Scholar
Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617–21.10.1056/NEJM1990060732223012342522Search in Google Scholar
Afenyi-Annan A, Willis MS, Konrad TR, Lottenberg R. Blood bank management of sickle cell patients at comprehensive sickle cell centers. Transfusion 2007;47:2089–97.10.1111/j.1537-2995.2007.01434.x17958539Search in Google Scholar
Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562–9.10.1046/j.1537-2995.1994.34794330008.x8053036Search in Google Scholar
Castilho L, Rios M, Bianco C, et al. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients. Transfusion 2002;42:232–8.10.1046/j.1537-2995.2002.00029.x11896340Search in Google Scholar
Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684–90.10.1046/j.1537-2995.2002.00126.x12147019Search in Google Scholar
Osby M, Shulman IA. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005;129:190–3.10.5858/2005-129-190-PMODRB15679419Search in Google Scholar
Olujohungbe A, Hambleton I, Stephens L, Serjeant B, Serjeant G. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001;113:661–5.10.1046/j.1365-2141.2001.02819.x11380455Search in Google Scholar
Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002;42:37–43.10.1046/j.1537-2995.2002.00007.x11896310Search in Google Scholar
Price CL, Boyd JH, Watkins AR, Fleming F, DeBaun MR. Mailing of a sickle cell disease educational packet increases blood donors within an African American community. Transfusion 2006;46:1388–93.10.1111/j.1537-2995.2006.00907.x16934076Search in Google Scholar
Rosenstock IM. Historical origins of the health belief model. Health Educ Monogr 1974;2:328–35.10.1177/109019817400200403Search in Google Scholar
Steinberg D. Altruism in medicine: its definition, nature, and dilemmas. Camb Q Healthc Ethics 2010;19:249–57.10.1017/S096318010999052120226108Search in Google Scholar
Lindsey T, Watts-Tate N, Southwood E, et al. Chronic blood transfusion therapy practices to treat strokes in children with sickle cell disease. J Am Acad Nurse Pract 2005;17:277–82.10.1111/j.1745-7599.2005.0046.x15982248Search in Google Scholar
Shaz BH, Demmons DG, Hillyer KL, Jones RE, Hillyer CD. Racial differences in motivators and barriers to blood donation among blood donors. Arch Pathol Lab Med 2009;133:1444–7.10.5858/133.9.1444Search in Google Scholar
Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011;51:1732–9.10.1111/j.1537-2995.2010.03045.xSearch in Google Scholar
Powars D, Wilson B, Imbus C, Pegelow C, Allen J. The natural history of stroke in sickle cell disease. Am J Med 1978;65: 461–71.10.1016/0002-9343(78)90772-6Search in Google Scholar
Pegelow CH, Adams RJ, McKie V, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995;126:896–9.10.1016/S0022-3476(95)70204-0Search in Google Scholar
McPherson ME, Anderson AR, Haight AE, et al. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor. Transfusion 2009;49:1977–86.10.1111/j.1537-2995.2009.02213.x19453984Search in Google Scholar
Lucarelli G, Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev 2008;22:53–63.10.1016/j.blre.2007.10.00118039551Search in Google Scholar
Boulware LE, Ratner LE, Cooper LA, Sosa JA, LaVeist TA, Powe NR. Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs. Med Care 2002;40:85–95.10.1097/00005650-200202000-0000311802081Search in Google Scholar
Boulware LE, Ratner LE, Ness PM, et al. The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. Transfusion 2002;42: 669–78.10.1046/j.1537-2995.2002.00120.x12147017Search in Google Scholar
Shaz BH, James AB, Demmons DG, Schreiber GB, Hillyer CD. The African American church as a donation site: motivations and barriers. Transfusion 2010;50:1240–8.10.1111/j.1537-2995.2009.02570.x20088834Search in Google Scholar
Grossman B, Watkins AR, Fleming F, DeBaun MR. Barriers and motivators to blood and cord blood donations in young African-American women. Am J Hematol 2005;78:198–202.10.1002/ajh.2030815726598Search in Google Scholar
